Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
Xiao Z, Wang CQ, Zhou MH, Li NN, Liu SY, He YJ, Wang YZ, Feng JH, Yao XS, Chen L, Ma B, Yu S, Zeng XT, Li CW, Ding J.
Xiao Z, et al. Among authors: zeng xt.
Int Immunopharmacol. 2018 Aug;61:363-375. doi: 10.1016/j.intimp.2018.06.012. Epub 2018 Jun 23.
Int Immunopharmacol. 2018.
PMID: 29945024